albuterol/budesonide inhaled (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

AdultPediatric

Asthma

Fixed dose inhaler pending FDA approval for as needed treatment or prevention of bronchoconstriction and for prevention of exacerbations in patients with asthma

Asthma

Fixed dose inhaler pending FDA approval for as needed treatment or prevention of bronchoconstriction and for prevention of exacerbations in patients aged ≥4 years with asthma

Next:

Pharmacology

Mechanism of Action

Albuterol: Beta2-adrenergic bronchodilator

Budesonide: Anti-inflammatory corticosteroid; has potent glucocorticoid activity and weak mineralocorticoid activity

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.